Yahoo Web Search

Search results

1. • 

     Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip

     Motley Fool via Yahoo Finance· 6 months ago

     It's now a new ballgame for CRISPR Therapeutics (NASDAQ: CRSP). The company, along with its big...

2. • 

     CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

     Zacks via Yahoo Finance· 11 months ago

     In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $57.75, marking a -0.81% move...

3. • 

     3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow

     Motley Fool via Yahoo Finance· 6 months ago

     CRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...

4. • 

     Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.

     Motley Fool· 11 months ago

     If the consensus price target set by Wall Street analysts is to be believed, CRISPR Therapeutics...

5. • 

     Is It Too Late to Buy CRISPR Therapeutics Stock?

     Motley Fool via Yahoo Finance· 3 months ago

     CRISPR Therapeutics (NASDAQ: CRSP) is gaining in prominence. The gene-editing specialist has made tremendous clinical and regulatory progress since its...

6. • 

     3 Reasons to Buy CRISPR Therapeutics Stock, and 1 Reason to Sell

     Motley Fool· 10 months ago

     CRISPR Therapeutics (NASDAQ: CRSP) is one of the most innovative biotechs out there, and that means...

7. • 

     Crispr Therapeutics Stock: Bull vs. Bear

     Motley Fool· 2 years ago

     Crispr Therapeutics (NASDAQ: CRSP) may be about to prove the strength of its gene-editing technology. The biotech company is submitting its candidate to...

8. • 

     If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today

     Motley Fool· 6 months ago

     CRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...

9. • 

     Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy

     Motley Fool· 10 months ago

     With shares of CRISPR Therapeutics (NASDAQ: CRSP) down by 40% over the last 12 months, some...

10. • 

      Better Growth Stock: Moderna vs. CRISPR Therapeutics

      Motley Fool· 1 year ago

      Now is a great time to get in on biotech growth stocks. Many of them are trading lower than in the past -- yet, at the same time, they're closer than...